Literature DB >> 12605413

Effect of the lipid peroxidation product acrolein on tau phosphorylation in neural cells.

Alberto Gómez-Ramos1, Javier Díaz-Nido, Mark A Smith, George Perry, Jesús Avila.   

Abstract

A hallmark of several neurodegenerative disorders, including Alzheimer's disease and tauopathies, is the hyperphosphorylation of the microtubule-associated protein tau. Tau phosphorylation by proline-directed and non-proline-directed protein kinases has been tested using antibodies PHF1 and 12E8, respectively. The effect of the lipid peroxidation product acrolein on these modes of phosphorylation has been assayed. We have found that acrolein, a peroxidation product from arachidonic acid, increases the phosphorylation of tau at the site recognized by PHF-1 both in human neuroblastoma cells and in primary cultures of mouse embryo cortical neurons. Whereas the basal phosphorylation of tau protein at the PHF1 site seems to be largely mediated by glycogen synthase kinase-3 (which is also activated in response to Abeta peptide), the acrolein-induced tau hyperphosphorylation at the same site is also due to p38 stress-activated kinase. These results support the view that oxidative stress and subsequent formation of lipid peroxidation products may contribute to tau protein phosphorylation in Alzheimer's disease and tauopathies. Copyright 2002 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12605413     DOI: 10.1002/jnr.10525

Source DB:  PubMed          Journal:  J Neurosci Res        ISSN: 0360-4012            Impact factor:   4.164


  41 in total

Review 1.  Oxidative imbalance in Alzheimer's disease.

Authors:  Xiongwei Zhu; Hyoung-Gon Lee; Gemma Casadesus; Jesus Avila; Kelly Drew; George Perry; Mark A Smith
Journal:  Mol Neurobiol       Date:  2005       Impact factor: 5.590

Review 2.  Tau as a therapeutic target for Alzheimer's disease.

Authors:  A Boutajangout; E M Sigurdsson; P K Krishnamurthy
Journal:  Curr Alzheimer Res       Date:  2011-09       Impact factor: 3.498

Review 3.  Dietary omega 3 polyunsaturated fatty acids and Alzheimer's disease: interaction with apolipoprotein E genotype.

Authors:  P Barberger-Gateau; C Samieri; C Féart; M Plourde
Journal:  Curr Alzheimer Res       Date:  2011-08       Impact factor: 3.498

Review 4.  A Cerebrovascular Hypothesis of Neurodegeneration in mTBI.

Authors:  Danielle R Sullivan
Journal:  J Head Trauma Rehabil       Date:  2019 May/Jun       Impact factor: 2.710

5.  Lithium prevents acrolein-induced neurotoxicity in HT22 mouse hippocampal cells.

Authors:  Yingjuan Huang; Jian Qin; Meihui Chen; Xiaojuan Chao; Ziwei Chen; Charles Ramassamy; Rongbiao Pi; Minghua Jin
Journal:  Neurochem Res       Date:  2014-02-13       Impact factor: 3.996

6.  Restoration of glyoxalase enzyme activity precludes cognitive dysfunction in a mouse model of Alzheimer's disease.

Authors:  Swati S More; Ashish P Vartak; Robert Vince
Journal:  ACS Chem Neurosci       Date:  2012-12-04       Impact factor: 4.418

7.  Inhibition of serine palmitoyltransferase reduces Aβ and tau hyperphosphorylation in a murine model: a safe therapeutic strategy for Alzheimer's disease.

Authors:  Hirosha Geekiyanage; Aditi Upadhye; Christina Chan
Journal:  Neurobiol Aging       Date:  2013-03-23       Impact factor: 4.673

8.  Plasma antioxidants and brain glucose metabolism in elderly subjects with cognitive complaints.

Authors:  Agnese Picco; M Cristina Polidori; Michela Ferrara; Roberta Cecchetti; Dario Arnaldi; Mauro Baglioni; Silvia Morbelli; Patrizia Bastiani; Irene Bossert; Giuliana Fiorucci; Andrea Brugnolo; Massimo Eugenio Dottorini; Flavio Nobili; Patrizia Mecocci
Journal:  Eur J Nucl Med Mol Imaging       Date:  2013-12-03       Impact factor: 9.236

Review 9.  Chronic traumatic encephalopathy-integration of canonical traumatic brain injury secondary injury mechanisms with tau pathology.

Authors:  Jacqueline R Kulbe; Edward D Hall
Journal:  Prog Neurobiol       Date:  2017-08-26       Impact factor: 11.685

10.  The thioredoxin-like protein rod-derived cone viability factor (RdCVFL) interacts with TAU and inhibits its phosphorylation in the retina.

Authors:  Ram Fridlich; Francois Delalande; Céline Jaillard; Jun Lu; Laetitia Poidevin; Thérèse Cronin; Ludivine Perrocheau; Géraldine Millet-Puel; Marie-Laure Niepon; Olivier Poch; Arne Holmgren; Alain Van Dorsselaer; Jose-Alain Sahel; Thierry Léveillard
Journal:  Mol Cell Proteomics       Date:  2009-03-11       Impact factor: 5.911

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.